15-63048582-G-A

Variant summary

Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP6BS1BS2

The ENST00000404484.9(TPM1):​c.7G>A​(p.Gly3Arg) variant causes a missense change. The variant allele was found at a frequency of 0.0000379 in 1,528,492 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. G3G) has been classified as Benign.

Frequency

Genomes: 𝑓 0.000046 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000037 ( 0 hom. )

Consequence

TPM1
ENST00000404484.9 missense

Scores

2
11
3

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: 5.84
Variant links:
Genes affected
TPM1 (HGNC:12010): (tropomyosin 1) This gene is a member of the tropomyosin family of highly conserved, widely distributed actin-binding proteins involved in the contractile system of striated and smooth muscles and the cytoskeleton of non-muscle cells. Tropomyosin is composed of two alpha-helical chains arranged as a coiled-coil. It is polymerized end to end along the two grooves of actin filaments and provides stability to the filaments. The encoded protein is one type of alpha helical chain that forms the predominant tropomyosin of striated muscle, where it also functions in association with the troponin complex to regulate the calcium-dependent interaction of actin and myosin during muscle contraction. In smooth muscle and non-muscle cells, alternatively spliced transcript variants encoding a range of isoforms have been described. Mutations in this gene are associated with type 3 familial hypertrophic cardiomyopathy and dilated cardiomyopathy 1Y. [provided by RefSeq, Jun 2022]
TPM1-AS (HGNC:53635): (TPM1 antisense RNA)

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -9 ACMG points.

BP6
Variant 15-63048582-G-A is Benign according to our data. Variant chr15-63048582-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 43683.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Uncertain_significance=1}.
BS1
Variant frequency is greater than expected in population mid. gnomad4_exome allele frequency = 0.0000371 (51/1376170) while in subpopulation MID AF= 0.00208 (10/4808). AF 95% confidence interval is 0.00113. There are 0 homozygotes in gnomad4_exome. There are 31 alleles in male gnomad4_exome subpopulation. Median coverage is 34. This position pass quality control queck.
BS2
High AC in GnomAd4 at 7 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
TPM1NM_001018005.2 linkuse as main transcriptc.240+4430G>A intron_variant ENST00000403994.9 NP_001018005.1
TPM1-ASNR_147233.2 linkuse as main transcriptn.661C>T non_coding_transcript_exon_variant 2/2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
TPM1ENST00000403994.9 linkuse as main transcriptc.240+4430G>A intron_variant 1 NM_001018005.2 ENSP00000385107 A1P09493-1
TPM1-ASENST00000561241.1 linkuse as main transcriptn.806C>T non_coding_transcript_exon_variant 1/1

Frequencies

GnomAD3 genomes
AF:
0.0000460
AC:
7
AN:
152210
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00318
Gnomad NFE
AF:
0.0000735
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000719
AC:
9
AN:
125154
Hom.:
0
AF XY:
0.0000583
AC XY:
4
AN XY:
68656
show subpopulations
Gnomad AFR exome
AF:
0.000260
Gnomad AMR exome
AF:
0.000214
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000425
Gnomad OTH exome
AF:
0.000266
GnomAD4 exome
AF:
0.0000371
AC:
51
AN:
1376170
Hom.:
0
Cov.:
34
AF XY:
0.0000457
AC XY:
31
AN XY:
678786
show subpopulations
Gnomad4 AFR exome
AF:
0.0000347
Gnomad4 AMR exome
AF:
0.000201
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000233
Gnomad4 OTH exome
AF:
0.000140
GnomAD4 genome
AF:
0.0000460
AC:
7
AN:
152322
Hom.:
0
Cov.:
33
AF XY:
0.0000537
AC XY:
4
AN XY:
74492
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.0000653
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000735
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000117
Hom.:
0
Bravo
AF:
0.0000982
ExAC
AF:
0.0000149
AC:
1
Asia WGS
AF:
0.000289
AC:
1
AN:
3474

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineNov 14, 2014proposed classification - variant undergoing re-assessment, contact laboratory -
Ventricular fibrillation;C0151878:Prolonged QT interval Benign:1
Likely benign, criteria provided, single submitterresearchAgnes Ginges Centre for Molecular Cardiology, Centenary InstituteNov 21, 2017The TPM1 Gly3Arg variant has been identified previously in 1 (heterozygous) proband with left ventricular dilation, wall thinning (LMM, Pers. Comm). It has also been identified in 1 Saudi Arabian family with 2 children affected with DCM and 1 child affected with Patent Ductus Arteruisus, all 3 children were found to be homozygous for p.Gly3Arg, the heterozygous parents were not affected (Al Harbi K, et al., 2016). We identified this variant in 2 heterozygous probands, The first was diagnosed with Long QT. The second was diagnosed with idiopathic ventricular fibrillation, and has a family history of sudden death. The variant is found in Genome Aggregation Database (MAF=0.00007917, http://gnomad.broadinstitute.org/), and the Greater Middle Eastern variome project (MAF= 0.00304, http://igm.ucsd.edu/gme/) which is higher then expected for a genetic heart condition. In silico tools PolyPhen-2 and MutationTaster predict this variant to be benign, however SIFT predicts this variant to be "deleterious". In summary, the variant is unlikely to be causing disease as it is present in the general population at an elevated frequency, evidence suggests it may only cause disease when inherited in the homozygous form, furthermore the variant has not been identified in consistent phenotypes and 2/3 in silico tools predict the variant to be benign, therefore we classify TPM1 Gly3Arg as 'likely benign'. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Uncertain
0.016
T
BayesDel_noAF
Uncertain
0.090
CADD
Benign
21
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.27
.;T;.;.;.;T
Eigen
Uncertain
0.27
Eigen_PC
Uncertain
0.28
FATHMM_MKL
Uncertain
0.76
D
LIST_S2
Uncertain
0.92
D;D;D;D;D;D
M_CAP
Pathogenic
0.95
D
MetaRNN
Uncertain
0.55
D;D;D;D;D;D
MetaSVM
Uncertain
0.42
D
MutationTaster
Benign
1.0
D;D;D;D;D;D;D;D;N;N;N;N;N
PROVEAN
Benign
-1.6
N;N;.;N;N;N
REVEL
Uncertain
0.52
Sift
Uncertain
0.0010
D;D;.;D;D;D
Sift4G
Uncertain
0.041
D;D;.;D;D;D
Polyphen
0.99, 0.97
.;.;.;D;D;.
Vest4
0.19
MutPred
0.21
Gain of methylation at G3 (P = 0.0315);Gain of methylation at G3 (P = 0.0315);Gain of methylation at G3 (P = 0.0315);Gain of methylation at G3 (P = 0.0315);Gain of methylation at G3 (P = 0.0315);Gain of methylation at G3 (P = 0.0315);
MVP
0.38
ClinPred
0.63
D
GERP RS
3.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs397516490; hg19: chr15-63340781; API